UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Epidemiology of genital warts in the British population: implications for HPV vaccination programmes

Sonnenberg, P; Tanton, C; Mesher, D; King, E; Beddows, S; Field, N; Mercer, CH; ... Johnson, AM; + view all (2019) Epidemiology of genital warts in the British population: implications for HPV vaccination programmes. Sexually Transmitted Infections 10.1136/sextrans-2018-053786. (In press). Green open access

[thumbnail of Field_Epidemiology of genital warts in the British population. Implications for HPV vaccination programmes_Proof.pdf]
Preview
Text
Field_Epidemiology of genital warts in the British population. Implications for HPV vaccination programmes_Proof.pdf

Download (391kB) | Preview

Abstract

OBJECTIVES: To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in the British population, following the introduction of the bivalent (human papillomavirus (HPV)-16/18) vaccination programme in girls, and prior to the switch to quadrivalent (HPV-6/11/16/18) vaccine (offering direct protection against GWs) and compare this with GW diagnoses in the prevaccination era. METHODS: Natsal-3, a probability sample survey in Britain, conducted in 2010-2012, interviewed 9902 men and women aged 16-44. Natsal-2, conducted in 1999-2001, surveyed 11 161 men and women aged 16-44. Both surveys collected data on sexual behaviour and sexually transmitted infection diagnoses using computer-assisted interview methods. RESULTS: In Natsal-3, 3.8% and 4.6% of sexually experienced men and women reported ever having a diagnosis of GWs, with 1.3% of men and 1.7% of woman reporting a GWs diagnosis in the past 5 years. GWs were strongly associated with increasing partner numbers and condomless sex. Diagnoses were more frequent in men who have sex with men (MSM) (11.6% ever, 3.3% past 5 years) and in women reporting sex with women (10.8% ever, 3.6% past 5 years). In the age group who were eligible for vaccination at the time of Natsal-3 (16-20 years), a similar proportion of same-aged women reported a history of GWs in Natsal-2 (1.9%, 1.1-3.4) and Natsal-3 (2.6%, 1.5-4.4). CONCLUSIONS: These data provide essential parameters for mathematical models that inform cost-effectiveness analyses of HPV vaccination programmes. There was no evidence of population protection against GWs conferred by the bivalent vaccine. Even with vaccination of adolescent boys, vaccination should be offered to MSM attending sexual health clinics.

Type: Article
Title: Epidemiology of genital warts in the British population: implications for HPV vaccination programmes
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/sextrans-2018-053786
Publisher version: http://dx.doi.org/10.1136/sextrans-2018-053786
Language: English
Additional information: © Author(s) (or their employer[s]) 2019. Published by BMJ.This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0).
Keywords: HPV, genital warts, probability sample survey
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/10067624
Downloads since deposit
180Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item